Harris Williams Advises Velocity Clinical Research on its Sale to GHO Capital Partners LLP
Press release content from Business Wire. The AP news staff was not involved in its creation. Harris Williams Advises Velocity Clinical Research on its Sale to GHO Capital Partners LLP May 3, 2021 GMT RICHMOND, Va.--(BUSINESS WIRE)--May 3, 2021-- Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Velocity Clinical Research (Velocity), a portfolio company of NaviMed Capital (NaviMed), on its sale to Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO). Velocity is a leading integrated site organization for clinical trials. The tr...